ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy
about
Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.
P2860
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ctDNA dynamics: a novel indica ...... treated with anti-HER2 therapy
@en
ctDNA dynamics: a novel indica ...... reated with anti-HER2 therapy.
@nl
type
label
ctDNA dynamics: a novel indica ...... treated with anti-HER2 therapy
@en
ctDNA dynamics: a novel indica ...... reated with anti-HER2 therapy.
@nl
prefLabel
ctDNA dynamics: a novel indica ...... treated with anti-HER2 therapy
@en
ctDNA dynamics: a novel indica ...... reated with anti-HER2 therapy.
@nl
P2093
P2860
P356
P1433
P1476
ctDNA dynamics: a novel indica ...... treated with anti-HER2 therapy
@en
P2093
Haili Qian
Shanshan Chen
Wenjie Zhu
Xiuwen Guan
Xuefeng Xia
P2860
P304
66020-66031
P356
10.18632/ONCOTARGET.11791
P407
P577
2016-09-01T00:00:00Z